[{"AccountsPayableCurrent_0_Q1_USD":4976000.0,"AccruedMarketingCostsCurrent_0_Q1_USD":707000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":389000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":7651000.0,"MarketableSecuritiesCurrent_0_Q1_USD":222838000.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":480000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":275000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":100000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3837000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-12000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-7000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":68245000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":41690000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":84477000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1_Q1_USD":4000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":-20000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":61000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":-5100000.0,"EarningsPerShareDiluted_1_Q1_USD":0.25,"DepreciationDepletionAndAmortization_1_Q1_USD":238000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":5095000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":40562000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7988000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":39182000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":331755000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":70000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":93247000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":48469000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.05,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3082000.0,"OperatingLeasePayments_1_Q1_USD":391000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1541000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1571000.0,"OperatingLeaseLiability_0_Q1_USD":3112000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":49000.0,"LossContingencyAccrualProvision_1_Q1_USD":0.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1151000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1598000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2130000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":535000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4263000.0,"InventoryNoncurrent_0_Q1_USD":11063000.0,"InterestReceivableCurrent_0_Q1_USD":1400000.0,"InterestIncomeDebtSecuritiesAvailableForSaleOperating_1_Q1_USD":177000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":53208000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q1_USD":7988000.0,"OperatingLeaseExpense_1_Q1_USD":400000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":465528000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":42000.0,"NetIncomeLoss_1_Q1_USD":30065000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":33269000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":19734000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":205000.0,"LiabilitiesCurrent_0_Q1_USD":34075000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":445494000.0,"Liabilities_0_Q1_USD":36005000.0,"InventoryNet_0_Q1_USD":5084000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-351000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":6756000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2600000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":9117000.0,"CostsAndExpenses_1_Q1_USD":55536000.0,"CommonStockValue_0_Q1_USD":120000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":84477000.0,"AssetsCurrent_0_Q1_USD":344776000.0,"Assets_0_Q1_USD":445494000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":310000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":4210000.0,"AccountsReceivableNetCurrent_0_Q1_USD":26684000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5693000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":30114000.0,"ProfitLoss_1_Q1_USD":30065000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":6510000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":263000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":114575000.0,"OtherAssetsNoncurrent_0_Q1_USD":3441000.0,"NonoperatingIncomeExpense_1_Q1_USD":1471000.0,"EarningsPerShareBasic_1_Q1_USD":0.26,"CostOfGoodsAndServicesSold_1_Q1_USD":1878000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":27000000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":421000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1328000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":122226000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":480000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":100000.0,"ShareBasedCompensation_1_Q1_USD":7918000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":27535000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":26123000.0,"PreferredStockValue_0_Q1_USD":0.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":275000.0,"OperatingIncomeLoss_1_Q1_USD":37711000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-3676000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":19590000.0,"StockholdersEquity_0_Q1_USD":409489000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":880000.0,"TreasuryStockCommonValue_0_Q1_USD":62979000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200504"}]